These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34710729)

  • 1. Development and validation of an LC-MS/MS assay for the quantification of cintirorgon (LYC-55716) in mouse plasma and tissue homogenates.
    Heydari P; Li W; Schinkel AH; Beijnen JH; Sparidans RW
    J Pharm Biomed Anal; 2022 Jan; 207():114421. PubMed ID: 34710729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an LC-MS/MS method for the quantitative analysis of milciclib in human and mouse plasma, mouse tissue homogenates and tissue culture medium.
    Martínez-Chávez A; Tibben MM; Broeders J; Rosing H; Schinkel AH; Beijnen JH
    J Pharm Biomed Anal; 2020 Oct; 190():113516. PubMed ID: 32784092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a UPLC-MS/MS method with a broad linear dynamic range for the quantification of morphine, morphine-3-glucuronide and morphine-6-glucuronide in mouse plasma and tissue homogenates.
    Heydari P; Martins MLF; Rosing H; Hillebrand MJX; Gebretensae A; Schinkel AH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122403. PubMed ID: 33246879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of FGFR4 inhibitor BLU-554 in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
    Dogan-Topal B; Li W; Schinkel AH; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():116-123. PubMed ID: 30802754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium.
    Bruin MAC; Rosing H; Lucas L; Wang J; Huitema ADR; Schinkel AH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121723. PubMed ID: 31352204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioanalytical assay for the new-generation ROS1/TRK/ALK inhibitor repotrectinib in mouse plasma and tissue homogenate using liquid chromatography-tandem mass spectrometry.
    Li W; Perpinioti N; Schinkel AH; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122098. PubMed ID: 32278292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS quantitation of non-psychotropic cannabinoid cannabidiol in aqueous humor.
    Aebersold AS; Kumar A; Song ZH
    J Pharm Biomed Anal; 2023 May; 228():115324. PubMed ID: 36907022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of KRAS inhibitor sotorasib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
    Retmana IA; Loos NHC; Schinkel AH; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122718. PubMed ID: 33957355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an LC-MS/MS method for the quantification of KRAS
    Retmana IA; Çelebi N; Rijmers J; Schinkel AH; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123964. PubMed ID: 38103305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
    Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
    J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative bioanalytical assay for the tropomyosin receptor kinase inhibitor larotrectinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
    Sparidans RW; Wang Y; Schinkel AH; Schellens JHM; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():167-172. PubMed ID: 30396050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry.
    Martínez-Chávez A; Rosing H; Hillebrand M; Tibben M; Schinkel AH; Beijnen JH
    Anal Bioanal Chem; 2019 Aug; 411(20):5331-5345. PubMed ID: 31209549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates.
    Sparidans RW; Li W; Schinkel AH; Schellens JHM; Beijnen JH
    J Pharm Biomed Anal; 2018 Nov; 161():136-143. PubMed ID: 30149189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a high-throughput method for the quantitative analysis of D-amphetamine in rat blood using liquid chromatography/MS3 on a hybrid triple quadrupole-linear ion trap mass spectrometer and its application to a pharmacokinetic study.
    Cesari N; Fontana S; Montanari D; Braggio S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):21-8. PubMed ID: 19945359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative high-throughput determination of endogenous retinoids in human plasma using triple-stage liquid chromatography/tandem mass spectrometry.
    Gundersen TE; Bastani NE; Blomhoff R
    Rapid Commun Mass Spectrom; 2007; 21(7):1176-86. PubMed ID: 17330217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
    Susam MM; Wang J; Schinkel AH; Beijnen JH; Sparidans RW
    Biomed Chromatogr; 2022 Nov; 36(11):e5457. PubMed ID: 35855648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of an LC-MS/MS Method for Quantification of the Novel Antibacterial Candidate DA-7010 in Plasma and Application to a Preclinical Pharmacokinetic Study.
    Kwon MH; Lee DY; Kang HE
    Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33670597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pharmacokinetics, bioavailability and tissue distribution of agnuside following peroral and intravenous administration in mice using liquid chromatography tandem mass spectrometry.
    Ramakrishna R; Bhateria M; Singh R; Puttrevu SK; Bhatta RS
    J Pharm Biomed Anal; 2016 Jun; 125():154-64. PubMed ID: 27018507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.